AmpliTech Group, Inc. (NASDAQ: AMPG) will list its Series A and Series B rights on the Nasdaq Capital Market, with trading set to begin on February 3, 2026. The rights will trade under the symbols AMPGR for Series A and AMPGZ for Series B. Series A rights carry a subscription price of $5 per share and expire on July 18, 2026, while Series B rights are priced at $6 per share and expire on November 20, 2026.
The listing follows a recent equity raise that saw AmpliTech issue a unit subscription rights offering that raised over $9 million, followed by a registered direct offering on January 27, 2026 that generated approximately $9.042 million. Proceeds are earmarked for scaling manufacturing, advancing research and development, deepening vertical integration, pursuing strategic partnerships, and supporting working‑capital needs.
AmpliTech’s business focus spans RF microwave components and open‑radio‑access network (ORAN) 5G solutions, with expanding interests in quantum computing. The company reported record FY 2025 revenue of about $25 million, a 163 % year‑over‑year increase, and has reaffirmed FY 2026 revenue guidance of at least $50 million. While the company has not yet achieved profitability, analysts expect it to reach profitability within the current fiscal year as revenue growth accelerates and operating leverage improves.
CEO Fawad Maqbool said the rights listing “strengthens our liquidity position and signals confidence in the market’s demand for our securities.” He added that “our strategy has always been to stay ahead of technological shifts, and the convergence of ORAN and quantum computing is a perfect example,” underscoring the company’s focus on high‑growth, high‑margin technology segments.
Market observers note that the rights listing provides a new avenue for investors to participate in AmpliTech’s equity structure, potentially reducing dilution from future issuances. While valuation concerns remain due to the company’s current lack of profitability, the liquidity improvement and strong revenue trajectory are viewed as positive indicators for long‑term growth.
The rights listing enhances shareholder flexibility and supports AmpliTech’s capital strategy, positioning the company to fund expansion in 5G and quantum product lines while maintaining confidence in achieving profitability in the near term.
The content on EveryTicker is for informational purposes only and should not be construed as financial or investment advice. We are not financial advisors. Consult with a qualified professional before making any investment decisions. Any actions you take based on information from this site are solely at your own risk.